Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma in Severe COVID-19
NCT04712344Phase 2Unknown
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Jan 2021
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of COVID-19 convalescent plasma in coronavirus disease 2019 (COVID-19), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Status: unknown.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04712344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04712344.